Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
Tempus AITEM |
$160,000 |
 |
SolventumSOLV |
-$25,000 |
 |
HCA HealthcareHCA |
$25,000 |
 |
ProgynyPGNY |
-$8,000 |
 |
Waters CorporationWAT |
$8,000 |
Are Members of Congress Buying or Selling Abbott Laboratories?
3 members of the U.S. Congress have traded Abbott Laboratories (ABT) stock in the past 90 days, across 1 buy and 2 sells. Congressional trades are reported under the STOCK Act and are typically disclosed within 45 days of the transaction.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the ABT AI Score. For corporate insider activity, see ABT insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading Abbott Laboratories?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| Michael McCaul | Bought $75,000 | 3 | Jun 16, 2025 |
| Jefferson Shreve | Sold $75,000 | 1 | May 12, 2025 |
| Josh Gottheimer | Mixed $48,000 | 6 | May 27, 2026 |
| Gilbert Cisneros | Sold $24,000 | 5 | Jun 16, 2026 |
| Julie Johnson | Sold $32,000 | 4 | May 12, 2026 |
| Rich McCormick | Bought $24,000 | 4 | Jul 30, 2026 |
ABT Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Rich McCormick | Jul 30, 2026 | Sell | $1K – $15K |
| Rick Larsen | Jul 8, 2026 | Sell | $1K – $15K |
| Gilbert Cisneros | Jun 16, 2026 | Buy | $1K – $15K |
| Rich McCormick | Jun 12, 2026 | Buy | $1K – $15K |
| Ro Khanna | Jun 2, 2026 | Buy | $1K – $15K |
| Josh Gottheimer | May 27, 2026 | Sell | $1K – $15K |
| Gilbert Cisneros | May 15, 2026 | Sell | $1K – $15K |
| Julie Johnson | May 12, 2026 | Sell | $1K – $15K |
| Rich McCormick | Mar 19, 2026 | Buy | $1K – $15K |
| Gilbert Cisneros | Feb 10, 2026 | Sell | $1K – $15K |
| Thomas H. Kean | Jan 29, 2026 | Buy | $1K – $15K |
| Gilbert Cisneros | Dec 19, 2025 | Sell | $1K – $15K |
| Julie Johnson | Dec 18, 2025 | Sell | $1K – $15K |
| Julia Letlow | Dec 8, 2025 | Sell | $1K – $15K |
| Byron Donalds | Dec 4, 2025 | Sell | $1K – $15K |
| Gilbert Cisneros | Nov 18, 2025 | Buy | $1K – $15K |
| Julie Johnson | Nov 13, 2025 | Sell | $1K – $15K |
| Rich McCormick | Nov 5, 2025 | Buy | $1K – $15K |
| Ro Khanna | Oct 30, 2025 | Sell | $1K – $15K |
| Rick Larsen | Oct 6, 2025 | Buy | $1K – $15K |
| Julie Johnson | Aug 14, 2025 | Sell | $1K – $15K |
| Thomas H. Kean | Jul 21, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Jul 18, 2025 | Sell | $1K – $15K |
| Lisa McClain | Jul 10, 2025 | Sell | $1K – $15K |
| Lisa McClain | Jun 24, 2025 | Buy | $1K – $15K |
| Michael McCaul | Jun 16, 2025 | Sell | $15K – $50K |
| Jefferson Shreve | May 12, 2025 | Sell | $50K – $100K |
| Bruce Westerman | Apr 21, 2025 | Sell | $1K – $15K |
| Byron Donalds | Mar 20, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Mar 6, 2025 | Sell | $1K – $15K |
| Bruce Westerman | Mar 3, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Feb 13, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Jan 29, 2025 | Buy | $1K – $15K |
| Josh Gottheimer | Jan 28, 2025 | Buy | $1K – $15K |
| Jared Moskowitz | Jan 15, 2025 | Sell | $1K – $15K |
| Emily Randall | Jan 6, 2025 | Sell | $1K – $15K |
| Thomas H. Kean | Dec 16, 2024 | Buy | $1K – $15K |
| Michael McCaul | Nov 19, 2024 | Sell | $15K – $50K |
| Michael McCaul | Nov 4, 2024 | Buy | $50K – $100K |
| Julia Letlow | Oct 23, 2024 | Buy | $1K – $15K |
Frequently Asked Questions: Abbott Laboratories Congress Trading
In the past 90 days, members of Congress have made 1 purchase and 2 sales of ABT stock. The net selling may reflect profit-taking or reduced exposure. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Rich McCormick sold Abbott Laboratories (ABT) stock most recently, on July 30, 2026.
The estimated net value of congressional trades in Abbott Laboratories over the past 2 years is negative, at -$82,000, meaning members of Congress have on balance sold more than they have bought.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
